| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ANTHEM INC | 100,000 | 14,000,000 | 5.51% | ||
| 2 | DEXCOM INC | 15,000 | 12,879,000 | 5.07% | Call | |
| 3 | PFIZER INC | 400,000 | 12,564,000 | 4.94% | Call | |
| 4 | VALEANT PHARMACEUTICALS INTL | 65,000 | 11,595,000 | 4.56% | ||
| 5 | ULTRAGENYX PHARMACEUTICAL INC COM | 110,000 | 10,594,000 | 4.17% | ||
| 6 | GILEAD SCIENCES INC | 100,000 | 9,819,000 | 3.86% | ||
| 7 | CELGENE CORP | 90,000 | 9,735,000 | 3.83% | ||
| 8 | PFIZER INC | 300,000 | 9,423,000 | 3.71% | ||
| 9 | AMGEN INC | 65,000 | 8,991,000 | 3.54% | ||
| 10 | BIOGEN INC | 30,000 | 8,754,000 | 3.44% | ||
| 11 | EDWARDS LIFESCIENCES CORP | 60,000 | 8,530,000 | 3.35% | ||
| 12 | EXPRESS SCRIPTS HLDG CO | 75,000 | 6,072,000 | 2.39% | ||
| 13 | TEVA PHARMACEUTICAL INDS LTD | 100,000 | 5,646,000 | 2.22% | ||
| 14 | MCKESSON CORP | 30,000 | 5,551,000 | 2.18% | ||
| 15 | AETNA INC NEW | 50,000 | 5,471,000 | 2.15% | ||
| 16 | CIGNA CORPORATION | 40,000 | 5,401,000 | 2.12% | ||
| 17 | NOVADAQ TECHNOLOGIES INC | 500,000 | 5,215,000 | 2.05% | ||
| 18 | MEDTRONIC PLC | 75,000 | 5,021,000 | 1.97% | ||
| 19 | ENDO INTL | 70,000 | 4,850,000 | 1.91% | ||
| 20 | MYLAN N V | 110,000 | 4,429,000 | 1.74% | ||
| 21 | HORIZON PHARMA PLC | 200,000 | 3,964,000 | 1.56% | ||
| 22 | MERCK & CO | 75,000 | 3,704,000 | 1.46% | Call | |
| 23 | GW PHARMACEUTICALS PLC | 40,000 | 3,655,000 | 1.44% | ||
| 24 | LA JOLLA PHARMACEUTICAL CO | 125,000 | 3,474,000 | 1.37% | ||
| 25 | ABBVIE INC | 60,000 | 3,264,000 | 1.28% | Call | |
| 26 | ALLSCRIPTS HEALTHCARE | 260,000 | 3,224,000 | 1.27% | ||
| 27 | VCA INCORPORATED | 60,000 | 3,159,000 | 1.24% | ||
| 28 | WRIGHT MEDICAL GROUP N.V. | 150,000 | 3,059,000 | 1.20% | ||
| 29 | MEDIVATION INC | 70,000 | 2,975,000 | 1.17% | ||
| 30 | GLOBAL BLOOD THERAPEUTICS IN COM | 65,000 | 2,740,000 | 1.08% | ||
| 31 | ACCELERON PHARMA | 110,000 | 2,739,000 | 1.08% | ||
| 32 | IMPAX LABORATORIES INC | 75,000 | 2,641,000 | 1.04% | ||
| 33 | ACCELERATE DIAGNOSTICS INC | 150,000 | 2,427,000 | 0.95% | ||
| 34 | NUVASIVE INC COM | 50,000 | 2,411,000 | 0.95% | ||
| 35 | WRIGHT MEDICAL GROUP NV | 100,000 | 2,102,000 | 0.83% | ||
| 36 | SPARK THERAPEUTICS INC | 50,000 | 2,087,000 | 0.82% | Put | |
| 37 | ONCOMED PHARMACEUTICALS INC | 125,000 | 2,074,000 | 0.82% | ||
| 38 | SUPERNUS PHARMACEUTICALS INC COM | 135,000 | 1,894,000 | 0.74% | ||
| 39 | ENDOLOGIX INC | 150,000 | 1,839,000 | 0.72% | ||
| 40 | HEALTHWAYS INC | 160,000 | 1,779,000 | 0.70% | ||
| 41 | DERMIRA INC | 75,000 | 1,751,000 | 0.69% | ||
| 42 | SAGE THERAPEUTICS | 40,000 | 1,693,000 | 0.67% | ||
| 43 | VANDA PHARMACEUTICALS INC COM | 150,000 | 1,692,000 | 0.67% | ||
| 44 | APPLIED GENETIC TECHNOL CORP | 125,000 | 1,643,000 | 0.65% | ||
| 45 | PTC THERAPEUTICS INC | 60,000 | 1,602,000 | 0.63% | Call | |
| 46 | ARIAD PHARMACEUTICALS INC | 250,000 | 1,460,000 | 0.57% | Call | |
| 47 | ASSEMBLY BIOSCIENCES INC | 150,000 | 1,434,000 | 0.56% | ||
| 48 | EPIZYME INC COM | 110,000 | 1,415,000 | 0.56% | ||
| 49 | BROOKDALE SR LIVING INC | 60,000 | 1,378,000 | 0.54% | ||
| 50 | CONATUS PHARMACEUTICALS INC COM | 300,000 | 1,335,000 | 0.53% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001597549-15-000013, filed 2015.11.16).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
